High yields. Low valuations. But with a couple of downsides to be aware of.
News & Analysis: CVS Health
Despite rapidly changing dynamics in the pharmaceutical industry, CVS Health looks like the clear leader.
For a few companies, the second half of 2019 will probably work out better than investors dared hope for earlier this year.
CVS earnings call for the period ending June 30, 2019.
The big healthcare company beat its earnings guidance with help from Aetna, higher brand drug prices, and a shift in the Easter holiday.
Wednesday morning brought selling for the stock market.
Better-than-expected Q2 results are making investors happy.
A low subscription price for free fast shipping and other perks? Sounds familiar. And the pharmacy chain may be debuting it just in time.
Look for plenty of good news when the healthcare giant reports its Q2 results on Wednesday.
Which retail drugstore chain is more worthy of your investment dollars?